{"id":692423,"date":"2022-10-05T09:04:54","date_gmt":"2022-10-05T13:04:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/"},"modified":"2022-10-05T09:04:54","modified_gmt":"2022-10-05T13:04:54","slug":"prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/","title":{"rendered":"ProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase"},"content":{"rendered":"
\n

SAN FRANCISCO, Oct. 05, 2022 (GLOBE NEWSWIRE) — ProSomnus Holdings Inc. (\u201cProSomnus\u201d), the leader in patient preferred medical devices for the treatment of obstructive sleep apnea (OSA), today announced that Laing Rikkers, Executive Chairwoman and Co-Founder, is scheduled to participate at the Oppenheimer Private Company Showcase on October 17-18, 2022 at the Four Seasons in Palo Alto, California. Laing Rikkers will present at 10:25 am Pacific Time, and will be available for investor meetings throughout both days.<\/p>\n

\n About ProSomnus<\/strong>
\n
ProSomnus is the first manufacturer of precision, mass-customized oral appliance therapy devices to treat OSA, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus\u2019s patented devices are a more comfortable and less invasive alternative to Continuous Positive Airway Pressure (CPAP) therapy, and lead to more effective and patient-preferred outcomes. With more than 150,000 patients treated, ProSomnus\u2019s devices are the most prescribed oral appliance therapy in the U.S. To learn more, visit\u00a0www.ProSomnus.com<\/a>.<\/p>\n

In May 2022, ProSomnus entered a definitive merger agreement with Lakeshore Acquisition I Corp. (Nasdaq: LAAA), a special purpose acquisition company. Upon closing, the combined company is expected to change its name to ProSomnus, Inc. and its Class A common stock is expected to be traded on the Nasdaq Capital Market under the symbol \u201cOSA\u201d.<\/p>\n

\n Contacts<\/strong>\n <\/p>\n

\n Media<\/strong>
\n
Sean Leous
Sean.Leous@westwicke.com<\/a><\/p>\n

\n Investors<\/strong>
\n
Mike Cavanaugh
Mike.Cavanaugh@westwicke.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN FRANCISCO, Oct. 05, 2022 (GLOBE NEWSWIRE) — ProSomnus Holdings Inc. (\u201cProSomnus\u201d), the leader in patient preferred medical devices for the treatment of obstructive sleep apnea (OSA), today announced that Laing Rikkers, Executive Chairwoman and Co-Founder, is scheduled to participate at the Oppenheimer Private Company Showcase on October 17-18, 2022 at the Four Seasons in Palo Alto, California. Laing Rikkers will present at 10:25 am Pacific Time, and will be available for investor meetings throughout both days. About ProSomnus ProSomnus is the first manufacturer of precision, mass-customized oral appliance therapy devices to treat OSA, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus\u2019s patented devices … <\/p>\n

Continue reading “ProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-692423","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO, Oct. 05, 2022 (GLOBE NEWSWIRE) — ProSomnus Holdings Inc. (\u201cProSomnus\u201d), the leader in patient preferred medical devices for the treatment of obstructive sleep apnea (OSA), today announced that Laing Rikkers, Executive Chairwoman and Co-Founder, is scheduled to participate at the Oppenheimer Private Company Showcase on October 17-18, 2022 at the Four Seasons in Palo Alto, California. Laing Rikkers will present at 10:25 am Pacific Time, and will be available for investor meetings throughout both days. About ProSomnus ProSomnus is the first manufacturer of precision, mass-customized oral appliance therapy devices to treat OSA, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus\u2019s patented devices … Continue reading "ProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-05T13:04:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTQ1OCM1MTg4ODA4IzIyNDQ3MTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase\",\"datePublished\":\"2022-10-05T13:04:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\\\/\"},\"wordCount\":244,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1OTQ1OCM1MTg4ODA4IzIyNDQ3MTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\\\/\",\"name\":\"ProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1OTQ1OCM1MTg4ODA4IzIyNDQ3MTE=\",\"datePublished\":\"2022-10-05T13:04:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1OTQ1OCM1MTg4ODA4IzIyNDQ3MTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1OTQ1OCM1MTg4ODA4IzIyNDQ3MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/","og_locale":"en_US","og_type":"article","og_title":"ProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase - Market Newsdesk","og_description":"SAN FRANCISCO, Oct. 05, 2022 (GLOBE NEWSWIRE) — ProSomnus Holdings Inc. (\u201cProSomnus\u201d), the leader in patient preferred medical devices for the treatment of obstructive sleep apnea (OSA), today announced that Laing Rikkers, Executive Chairwoman and Co-Founder, is scheduled to participate at the Oppenheimer Private Company Showcase on October 17-18, 2022 at the Four Seasons in Palo Alto, California. Laing Rikkers will present at 10:25 am Pacific Time, and will be available for investor meetings throughout both days. About ProSomnus ProSomnus is the first manufacturer of precision, mass-customized oral appliance therapy devices to treat OSA, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus\u2019s patented devices … Continue reading \"ProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/","og_site_name":"Market Newsdesk","article_published_time":"2022-10-05T13:04:54+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTQ1OCM1MTg4ODA4IzIyNDQ3MTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase","datePublished":"2022-10-05T13:04:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/"},"wordCount":244,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTQ1OCM1MTg4ODA4IzIyNDQ3MTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/","name":"ProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTQ1OCM1MTg4ODA4IzIyNDQ3MTE=","datePublished":"2022-10-05T13:04:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTQ1OCM1MTg4ODA4IzIyNDQ3MTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTQ1OCM1MTg4ODA4IzIyNDQ3MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ProSomnus\u00ae Sleep Technologies to Participate at the Oppenheimer Private Company Showcase"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=692423"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692423\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=692423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=692423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=692423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}